Board approves healthcare demerger into Saarathi, BeamOptics buyout

Listed-company acquisitionDemerger ratio announcedStrategic Transactions View source PDF Explain this filing

QMSMEDI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.8%Reaction day

₹199.00

prior close

₹206.47

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%+5.3% vs market

On the reaction day the stock moved 5.3 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs market

Reaction day

+3.8-1.6+5.3

Next day

+8.9-0.6+9.5

+3.5-0.8+4.3

-1.7-2.1+0.4

-6.6-2.1-4.5

-2.5-0.8-1.7

-3.5-3.8+0.3

15d

-12.6-6.9-5.7

-11.1-8.0-3.0

———

UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

QMS board approved a composite scheme to demerge its Healthcare Services Business (Rs 37.17 Cr, 24.41 percent of turnover) and HCAH's healthcare arm into Saarathi Healthcare. Share swap 1:1 for QMS holders; Saarathi to seek NSE listing. QMS also signed an MOU to buy 100 percent of BeamOptics Scientific (diagnostics maker, FY26 revenue Rs 113.81 lakh). Consideration to be set by independent valuer, target completion Nov 30, 2027. Steps need NCLT and other approvals.

Likely market impact

Shareholders get shares in new listed Saarathi while keeping QMS. BeamOptics buy broadens healthcare diagnostics reach. Pending NCLT and other approvals.